This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Relationship: 2839
Title
Increase, Pro-Inflammatory Mediators leads to Impairment, Learning and memory
Upstream event
Downstream event
Key Event Relationship Overview
AOPs Referencing Relationship
AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding | Point of Contact | Author Status | OECD Status |
---|---|---|---|---|---|---|
Deposition of Energy Leading to Learning and Memory Impairment | non-adjacent | Moderate | Low | Vinita Chauhan (send email) | Open for citation & comment |
Taxonomic Applicability
Sex Applicability
Sex | Evidence |
---|---|
Unspecific | Moderate |
Life Stage Applicability
Term | Evidence |
---|---|
All life stages | Moderate |
Key Event Relationship Description
Inflammatory mediators such as IL-1β, TNF-α, and IL-6, can influence the normal behavior of neuronal cells and their functional connection. Overexpression of pro-inflammatory mediators disrupts the integrity and function of the neuronal network through decreased neurogenesis, synaptic complexity and increased necrosis and demyelination, ultimately impairing learning and memory (Cekanaviciute, Rosi, & Costes, 2018; Fan & Pang, 2017). Impaired short-term and long-term memory, as well as associative learning are consequences of the dysregulated expression of pro-inflammatory cytokines as reported in behavioural paradigms (Donzis & Tronson, 2014).
Under physiological conditions, cytokine levels are low but greatly increased in response to various insults. Cytokines mediate immune response through ligand binding to cell surface receptors, which activate signaling cascades such as the JAK-STAT or MAPK pathways to produce or recruit more cytokines. Once organs initiate inflammatory reactions, the cytokines can modulate different metabolic and molecular pathways that have direct effects on neurons or indirect effects mediated by microglia, astrocytes or vascular endothelial cells (Mousa & Bakhiet, 2013; Prieto & Cotman, 2018). Modulation of these pathways ultimately affects crucial neuronal networks such as that within the hippocampus, which is one of the main brain regions responsible for learning and memory (Barrientos et al., 2015; Bourgognon & Cavanagh, 2020).
Evidence Collection Strategy
The strategy for collating the evidence to support the relationship is described in Kozbenko et al 2022. Briefly, a scoping review methodology was used to prioritize studies based on a population, exposure, outcome, endpoint statement.
Evidence Supporting this KER
Overall Weight of Evidence: Moderate
Biological Plausibility
Several reviews provide support of biological plausibility between increase in pro-inflammatory mediators and impaired learning and memory. In the central nervous system, cytokines and their receptors are constitutively expressed and affect brain plasticity, which is the ability to modify its activity and connections in response to intrinsic or extrinsic stimuli. In a pathological state, pro-inflammatory, or Th-1 type cytokines become particularly relevant in the brain and these cytokines bind to their receptors to induce a conformational change and activate intracellular signaling pathways (Mousa & Bakhiet, 2013). The main cytokines presenting detrimental effects are IL-1β, TNF-α and IL-6, as these are the most studied.
The mechanism by which these cytokines modify learning and memory processes are not clearly understood due to the complexity of inflammatory signaling, although it involves alterations in the neural circuits that regulate these processes (Bourgognon & Cavanagh, 2020; Pugh et al., 2001). Multiple studies have demonstrated that IL-1β presents a critical role in the formation of hippocampal dependent memory, as IL-1β and its receptor are highly expressed in the hippocampus. Experimentally elevated levels of IL-1β in the hippocampus lead to impaired performance in behavioral paradigms such as spatial memory, contextual learning, and passive avoidance tasks (Donzis & Tronson, 2014; Pugh et al. 2001; Yirmiya & Goshen, 2011).
There are several possible mechanisms for this detrimental effect. One proposed mechanism is through reduced N-methyl-d-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor functions, both of which are involved in long-term potentiation, a process that strengthens synaptic connections between neurons. Other potential mechanisms for the effects of IL-1β on brain plasticity and memory can involve the activation of several pathways such as p38 mitogen-activated protein kinase (MAPK), c-jun NH2-terminal kinase (JNK), caspase 1, nuclear factor kappa B (NF-kB), and brain-derived neurotrophic factor (BDNF). These complex pathways have roles in neuronal health, long-term potentiation, brain plasticity and ultimately learning and memory (Patterson, 2015). The mechanisms of IL-6 and TNF-α in terms of impaired cognition also remain unclear, although the pathways that these cytokines activate are similar to those of IL-1β due to the network of cytokine interactions (Donzis & Tronson, 2014).
Empirical Evidence
The empirical evidence collected for this KER comes from in-vivo studies and various methods used to assess the impairment in learning and memory. The behavioral paradigms test associative learning, as well as long and short-term memory (Bourgognon & Cavanagh, 2020).
Various studies also examined the presence of pro-inflammatory mediators induced by lipopolysaccharide (LPS) injections (Sparkman et al., 2006), Escherichia coli (E. coli) injections (Barrientos et al., 2009), direct cytokine injections (Gonzalez et al., 2009; Goshen et al., 2007; Taepavarapruk & Song, 2010), ionizing radiation (Bhat et al., 2020; Jenrow et al., 2013), surgical procedures (Tan et al., 2014) and transgenic models with overexpressed pro-inflammatory cytokines (Hein et al., 2010; Heyser et al., 1997; Moore et al., 2009).
Dose Concordance
Dose concordance relating an increase in pro-inflammatory mediators leading to an impaired learning and memory was demonstrated using various stressors, including ionizing radiation, LPS, IL-1β, and E. coli injections.
A 10 Gy X-ray irradiation in mice led to an increase in IL-6 secretion compared to dimethyl sulfoxide (DMSO) control. Impaired learning and memory were assessed by a decrease in freezing time in fear conditioning tests and a decrease in novel object recognition and object in place discrimination index (DI) (Bhat et al., 2020). A 10 Gy gamma irradiation of rats’ brains similarly indicated impaired cognitive function and an increase in OX-6+ cell density, indicative of inflammation (Jenrow et al., 2013).
Rats injected with 2.5x109 CFU of E. coli showed a significant increase in IL-1β in multiple regions of the brain, spleen and serum, along with impaired memory and learning as indicated by fear conditioning (Barrientos et al., 2009). Mice injected with 100 µg of LPS demonstrated an increase in IL-1β, TNF-α, IL-6 and IL-10 levels, while the performance in a Morris water maze was impaired, indicating impairments in spatial memory (Sparkman et al., 2006)..
Time Concordance
Various studies show that an increase in pro-inflammatory mediators is observed before or at the same time as impaired learning and memory. Some studies observe each event at the same time at specific timepoints. In mice injected with LPS, an increase in IL-1β, TNF-α, IL-6 and IL-10 was observed after 4 hours, while impaired learning and memory were also consistently observed 4 h after LPS injection (Sparkman et al., 2006). Both key events were also found in rats from 4 h to 8 days after E. coli injection (Barrientos et al., 2009). Cohort studies using age as a stressor in humans found increased pro-inflammatory mediators and decreased cognitive function over 6 months (Holmes et al., 2009) and 7 years (Alley et al., 2008). Many studies observe increased pro-inflammatory mediators occurring before impaired learning and memory. Rats with hippocampal injections of IL-1β showed impaired memory 24 h and 7 days later (Gonzalez et al., 2009). Rats showed increased hippocampal IL-1β and IL-6 levels 6 h after surgery to expose the right carotid artery, while learning and memory was impaired 2 weeks later (Tan et al., 2014). When mice were irradiated with X-rays, IL-6 was found to increase 24 h later, while learning and memory was impaired 5 weeks later (Bhat et al., 2020). Rats irradiated with gamma rays showed increased inflammation after 2 months, while memory was impaired after 6 months (Jenrow et al., 2013).
Incidence Concordance
Some evidence also shows that pro-inflammatory mediators increase equal to or greater than the amount that impairs learning and memory at the same stressor severity. Many of these studies were done with transgenic mice expressing IL-1β or IL6 as a stressor and showed increased levels of various pro-inflammatory mediators including ICAM-1, CCL2, IL-1α, COX-1 and MCP-1 from 2- to 147-fold, while learning and memory were decreased a maximum of 0.6-fold (Hein et al., 2010; Heyser et al., 1997; Moore et al., 2009).
Other Evidence
Multiple longitudinal cohort studies followed hundreds to thousands of older adults over the course of several years ranging from four to sixteen years and examined the relationship between pro-inflammatory marker levels and the rate of cognitive change over time. These studies reported linear negative correlations between IL-6 and TNF-α levels and learning and memory ability as the populations aged (Alley et al., 2010; Holmes et al., 2009; Schram et al., 2007).
Essentiality
Studies show that overexpression of pro-inflammatory cytokines affect learning and memory, and several treatments that alter the effects/function of pro-inflammatory mediators preserve cognitive function. The treatments included MW-151, a selective inhibitor of pro-inflammatory cytokine production, lidocaine, an anesthetic with anti-inflammatory properties, ethyl-eicosapentaenoate (E-EPA) and 1-[(4-nitrophenyl)sulfonyl]-4-phenylpiperazine (NSPP), both of which are anti-inflammatory drugs and α-melanocyte stimulating hormone (α-MSH), which antagonizes the effects of pro-inflammatory cytokines through G protein coupled receptors (Bhat et al., 2020; Gonzalez et al., 2009; Jenrow et al., 2013; Taepavarapruk and Song, 2010; Tan et al., 2014). More details are provided in the Modulating Factors section below.
Uncertainties and Inconsistencies
-
Due to the indirect linkage between the two key events, there is no clear understanding of how increases in pro-inflammatory mediators cause impaired learning and memory. (Donzis & Tronson, 2014).
-
A previous prospective population-based cohort study found an association between antihistamine use and increased risk of dementia, which is the loss of cognitive functioning. Therefore, anti-inflammatory medications such as antihistamines could modulate the progression to impaired learning and memory (Gray et al., 2015).
Known modulating factors
Modulating factor |
Details |
Effects on the KER |
References |
Drug |
NSPP (anti-inflammatory drug) |
There was a 0.35-fold decrease in IL-6 levels compared to controls when 10 Gy irradiated mice were treated with NSPP. Mice that were exposed to whole brain irradiation (10 Gy) and treated with NSPP (5 mg/kg) exhibited significantly improved performance in novel object recognition and object in place. |
Bhat et al., 2020 |
Drug |
α-MSH (modulator of action of pro-inflammatory cytokines) |
α-MSH injected into the hippocampus prevented the IL-1β-induced decrease in contextual fear memory. |
Gonzalez et al., 2009 |
Drug |
MW-151 (inhibitor of pro-inflammatory microglial cytokine production) |
Treatment decreased the OX-6+ cell density and restored memory. |
Jenrow et al., 2013 |
Drug |
Lidocaine (an anti-inflammatory local anesthetic) |
Lidocaine treatment restored IL-6 levels and improved memory. |
Tan et al., 2014 |
Age |
Young age |
Rats aged 3 months showed increased IL-1β levels in the hippocampus for less time than in mice aged 24 months. Hippocampal-dependent memory was impaired in the old mice. The inflammatory response is shorter and less severe in young individuals, leading to reduced cognitive impairment. |
Barrientos et al., 2009; Barrientos et al., 2012 |
Drug |
E-EPA (known to improve cognitive function through reducing inflammation) |
E-EPA reduced the increase in IL-6 expression and improved memory to control levels. |
Taepavarapruk & Song, 2010 |
Quantitative Understanding of the Linkage
The table below provides some representative examples of quantitative linkages between the two key events. It was difficult to identify a general trend across all the studies due to differences in experimental design and reporting of the data. All data is statistically significant unless otherwise stated.
Dose Concordance
Reference |
Experiment Description |
Result |
Sparkman et al., 2006 |
In-vivo. Three-month-old male C57BL/6 mice were injected with 100 µg of LPS. Pro-inflammatory mediator levels were determined with immunohistochemical staining. Spatial working memory was evaluated through a Morris water maze. |
IL-1β increased from 15 pg/mL (control) to 400 pg/mL. TNF-α increased from <5 pg/mL (control) to 360 pg/mL. IL-6 increased from undetectable levels (control) to 300 pg/mL. IL-10 increased from undetectable levels (control) to 260 pg/mL. Performance in the water maze was impaired in distance swam, latency and swim speed after LPS injection, with a maximum 2-fold increased swim distance. |
Taepavarapruk & Song, 2010 |
In-vivo. Male Long-Evans rats were administered 15 ng/µL/day of IL-1β for either 1 or 7 days. IL-1 expression was determined, and memory was assessed with an eight-arm radial maze. |
IL-1β administration of 105 ng/µL resulted in a 2.5-fold increase in IL-1 expression and a 1.5-fold increase in number of entries, indicating memory impairment. |
Goshen et al., 2007 |
In-vivo. 2–4-month-old male mice were injected with IL-1β and IL-1ra (IL-1 receptor antagonist) at 1 or 10 ng (injected in 10 µL) doses. IL-1β was assessed by quantitative real time RT-PCR, and hippocampal IL-1ra was determined by ELISA. Contextual fear conditioning was used to assess associative learning and memory. Evaluations were taken after 3 weeks of recovery. Water maze was used for spatial memory testing. |
Mice that were injected with a high dose of IL-1β (10 ng) had shorter freezing times, indicating impaired contextual fear conditioning, whereas mice injected with a low dose of IL-1β (1 ng) showed longer freezing times, indicating improved contextual fear conditioning. Spatial memory was impaired in IL-1raTG rats (astrocyte-directed overexpression of IL-1ra) as latency and path length was increased (non-significantly) in the majority of the trials compared to wild type rats. |
Gonzalez et al., 2009 |
In-vivo. Adult male Wistar rats had hippocampal injections of 5 ng/0.25 µL of IL-1β post-conditioning and memory was assessed through freezing behavior. |
Rats injected with 5 ng/0.25 µL IL-1β displayed impaired contextual fear memory, where injected rats spent 0.6-fold less time freezing. |
Bhat et al., 2020 |
In-vivo. Female mice were exposed to X-ray irradiation at 0, 2, 4 and 10 Gy (5.519 Gy/min). Novel object recognition, object in place and fear conditioning evaluated memory. IL-6 levels were measured by ELISA. |
There was a significant 2.97-fold increase in the secretion of IL-6 in cells irradiated with 10 Gy compared to DMSO control. DMSO was used as a control as treatment mice were also treated with NSPP solubilized in DMSO. Irradiated mice demonstrated a significant decrease in DI for novel object recognition and object in place. Irradiated mice also spent significantly less time freezing in context fear, context gen and pre-tone assessments of fear conditioning. |
Jenrow et al., 2013 |
In-vivo. Adult male Fischer 344 rats’ brains were irradiated with 10 Gy gamma rays. OX-6 levels (indicative of inflammation levels) were determined, and novel object recognition was performed to assess memory. |
10 Gy increased OX-6+ cell density from 1493±270 to 1966±218 cells/mm3. Also, after 10 Gy, the discrimination ratio for novel object recognition decreased from 68.76±11.30% to 21.71±10.86%. |
Barrientos et al., 2009 |
In-vivo. Male F344xBN F1 rats, either old (24 months) or young (3 months), received an injection of 2.5x109 CFU of E. coli. IL-1β levels were determined using ELISA and fear conditioning was performed to assess learning and memory. |
Significant increases in IL-1β were observed in the hippocampus, hypothalamus, parietal cortex, serum and spleen after injection, with a maximum 4-fold increase. Injected mice also spent 0.6-fold less time freezing. |
Time Concordance
Reference |
Experiment Description |
Result |
Sparkman et al., 2006 |
In-vivo. Three-month-old male C57BL/6 mice were injected with 100 µg of LPS. Pro-inflammatory mediator levels were determined with immunohistochemical staining and measured 4 h after LPS injection. Spatial working memory was evaluated 4 h after LPS injection through a Morris water maze. |
IL-1β increased from 15 pg/mL (control) to 400 pg/mL. TNF-α increased from <5 pg/mL (control) to 360 pg/mL. IL-6 increased from undetectable levels (control) to 300 pg/mL. IL-10 increased from undetectable levels (control) to 260 pg/mL. Performance in the water maze was found impaired in distance swam, latency and swim speed 4 h after LPS injection, with a maximum 2-fold increased swim distance. |
Gonzalez et al., 2009 |
In-vivo. Adult male Wistar rats had hippocampal injections of 5 ng/0.25 µL of IL-1β post-conditioning and memory was assessed through freezing behavior. |
Rats spent 0.6- to 0.7-fold less time freezing 24 h after injection with IL-1β. Rats also showed impaired long-term memory 7 days after injection when they spent 0.7-fold less time frozen. |
Bhat et al., 2020 |
In-vivo. Female mice were exposed to X-ray irradiation at 0, 2, 4 and 10 Gy (5.519 Gy/min). Novel object recognition, object in place and fear conditioning evaluated memory. IL-6 levels were measured by ELISA. |
24 hours after exposure to 10 Gy irradiation, mice showed a significant 2.97-fold increase in the secretion of IL-6 compared to DMSO control (DMSO was used as a control as mice were also treated with NSPP solubilized in DMSO). At week 5, irradiated mice demonstrated a significant decrease in DI for novel object recognition and object in place, and spent less time freezing in context fear, context gen and pre-tone assessments of fear conditioning. |
Jenrow et al., 2013 |
Adult male Fischer 344 rats’ brains were irradiated with 10 Gy 137Cs gamma rays. OX-6 levels (indicative of inflammation levels) were determined, and novel object recognition was performed to assess memory. |
After 2 months, OX-6+ cell density increased from 1493±270) to 1966±218 cells/mm3. A similar but smaller increase was found after 9 months. Only measured after 6 months, the discrimination ratio for novel object recognition decreased from 68.76±11.30% to 21.71±10.86%. |
Tan et al., 2014 |
In-vivo. Four-month-old male Fischer 344 rats had 1 cm of right carotid artery dissected free from surrounding tissue in a 15-minute surgery. IL-6 and IL-1β levels were determined by western blot and a Barnes maze was used to test spatial learning and memory. |
Surgery increased IL-1β and IL-6 in the hippocampus by 2- to 3-fold compared to controls 6 h after surgery. Additionally, rats in the surgery group took 2- to 3-fold more time to identify the target in the Barnes maze task 2 weeks after surgery. |
Barrientos et al., 2009 |
In-vivo. Male F344xBN F1 rats, either old (24 months) or young (3 months), received an injection of 2.5x109 CFU of E. coli. IL-1β levels were determined using ELISA and fear conditioning was performed to assess hippocampal-dependent learning and memory. |
Significant increases in IL-1β were observed in the hippocampus, hypothalamus, parietal cortex, serum and spleen most frequently 4 h after injection, with a maximum 4-fold increase. IL-1β in the hypothalamus was also increased in old mice up to 8 days after injection. Old mice spent less time freezing 4 days after injection, while old injected mice also spent 0.6-fold less time freezing 8 days after injection. |
Alley et al., 2008 |
In-vivo. A cohort study of older adults aged 70-79 years that were tested in 1988, 1991 and 1995 to determine changes in cognitive functioning and IL-6 levels. ELISA was used to measure IL-6 levels. Cognitive function was determined by various tests, including spatial recognition, spatial ability, verbal recall, language and abstraction. Short Portable Mental Status Questionnaire (SPMSQ) was used as a measure of cognitive performance. Participants were re-interviewed at 2.5 and 7 years. |
As IL-6 levels increased, mean cognitive scores decreased compared to baseline cognitive scores. A linear inverse association was found between inflammation and general cognitive scores, both measured at the end of the 7-year study. |
Holmes et al., 2009 |
In-vivo. A cohort study of subjects with mild to severe Alzheimer’s disease who were cognitively assessed and tested for inflammatory markers. Cognitive assessments were performed using the Alzheimer's Disease Assessment Scale (ADAS-COG) test. The sandwich immunoassay multiplex cytokine assay measured TNF-α at 2, 4 and 6 months |
Subjects with high TNF-α levels (3.2 [standard error (SE) 0.6]) at baseline observed greater changes in ADAS-COG over 6-months compared to subjects with low TNF-α (0.8 [SE 0.8]). The mean change in ADAS-COG score was 2.6 (±7.0) points over the 6 months. |
Incidence Concordance
Reference |
Experiment Description |
Result |
Moore et al., 2009 |
In-vivo. Transgenic mice overexpressing IL-1β (activated by microinjection of FIV-Cre) for 2 weeks underwent spatial and non-spatial behavioral tasks using a Morris water maze. IL-1β, IL-1α and MCP-1 were measured by RT-PCR. |
Measurement of IL-1β in hippocampal tissue revealed mRNA levels increased 22.9-fold. The pro-inflammatory mediators IL-1α and MCP-1 mRNA levels were also increased 3.1- and 147-fold, respectively. Overexpression of IL-1β in the hippocampus hindered acquisition and long-term memory retention on the spatial task but did not impact non-spatial learning. |
Hein et al., 2010 |
In-vivo. Male and female IL-1βXAT mice on a C57BL/6 background (containing a dormant human IL-1β gene activated by a virus expressing Cre) were injected with 1.5x104 viral particles of the feline immunodeficiency virus (expresses Cre) in the hippocampus. Fear conditioning and a Morris water maze were performed to assess learning and memory. |
IL-1β was increased 15-fold in the hippocampus, and the expression of other pro-inflammatory mediators CCL2, IL-1α and COX-1 were similarly increased. Mice spent 0.6-fold less time freezing and 0.8-fold less time in the target quadrant, indicating impaired learning and memory. No differences between males and females were observed. |
Heyser et al., 1997 |
In-vivo. C57BL/6 x SJL hybrid mice with a GFAP-IL6 fusion gene were tested for avoidance learning and expression of ICAM-1. |
Compared to non-transgenic (+/+) mice, ICAM-1 was increased 2-fold at 3 months old and 4-fold at 12 months old in both heterozygous (+/tg) and homozygous (tg/tg) transgenic mice. Also compared to +/+ mice, +/tg mice showed impaired avoidance response at 12 months old, where tg/tg mice showed impaired avoidance at 3, 6 and 12 months old. |
Other Evidence
Reference |
Experiment Description |
Result |
Alley et al., 2008 |
In-vivo. A cohort study of older adults aged 70 to 79 years that were tested in 1988, 1991 and 1995 to determine changes in cognitive functioning and IL-6 levels. ELISA was used to measure IL-6 levels. Cognitive function was determined by various tests, including spatial recognition, spatial ability, verbal recall, language and abstraction. Short Portable Mental Status Questionnaire (SPMSQ) was used as a measure of cognitive performance. Participants were re-interviewed at 2.5 and 7 years. |
As IL-6 levels increased, mean cognitive scores decreased compared to baseline cognitive scores. A linear inverse association was found between inflammation and general cognitive scores, both measured over the course of 7 years. Participants in the top IL-6 tertile (IL-6 > 3.8 pg/mL) had 62% increased odds of declines in global cognitive function (Odds Ratio (OR) = 1.62, 95% Confidence Interval (CI), 1.07–2.45). They also had 88% increased odds of cognitive impairment, (OR = 1.88, 95% CI, 1.20–2.94), relative to those with lower levels of IL-6. |
Holmes et al., 2009 |
In-vivo. A cohort study of subjects with mild to severe Alzheimer’s disease were cognitively assessed and tested for inflammatory markers. Cognitive assessments were performed using the Alzheimer's Disease Assessment Scale (ADAS-COG) test. The sandwich immunoassay multiplex cytokine assay measured TNF-α at 2, 4 and 6 months |
Subjects with high TNF-α levels (3.2 [SE 0.6]) at baseline observed greater changes in ADAS-COG over 6-months compared to subjects with low TNF-α (0.8 [SE 0.8]). The mean change in ADAS-COG score was 2.6 (SD 7.0) points over the 6 months. |
Schram et al., 2007 |
In-vivo. The Leiden 85-plus Study, performed with participants aged 85 to 90 years (n= 705), assessed memory function and its association with inflammatory markers. IL-6 plasma levels were measured by ELISA. C-reactive protein (CRP) pro-inflammatory mediator was measured by Rate Near Infrared Particle Immunoassay. The 12-Picture Learning Test was used to evaluate memory function. |
When levels of pro-inflammatory mediators were higher than baseline, delayed recall memory point estimate was negative, indicating impaired memory. |
Response-response Relationship
Time-scale
Known Feedforward/Feedback loops influencing this KER
Not identified.
Domain of Applicability
Evidence for this relationship comes from human, rat, and mouse models, with most of the evidence in mice. The relationship is not sex or life stage specific.
References
Alley, D. E. et al. (2008), "Inflammation and Rate of Cognitive Change in High-Functioning Older Adults", The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, Vol. 63/1, Oxford University Press, Oxford, https://doi.org/10.1093/gerona/63.1.50.
Alley, D. E. et al. (2008), "Inflammation and Rate of Cognitive Change in High-Functioning Older Adults", The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, Vol. 63/1, https://doi.org/10.1093/gerona/63.1.50.
Barrientos, R. M. et al. (2015), "Neuroinflammation in the normal aging hippocampus", Neuroscience, Vol. 309, Elsevier, Amsterdam, https://doi.org/10.1016/j.neuroscience.2015.03.007.
Barrientos, R. M. et al. (2009), "Time course of hippocampal IL-1 β and memory consolidation impairments in aging rats following peripheral infection", Brain, Behavior, and Immunity, Vol. 23/1, Elsevier, Amsterdam, https://doi.org/10.1016/j.bbi.2008.07.002.
Barrientos, R. M. et al. (2012), "Aging-related changes in neuroimmune-endocrine function: Implications for hippocampal-dependent cognition", Hormones and Behavior, Vol. 62/3, Elsevier, Amsterdam, https://doi.org/10.1016/j.yhbeh.2012.02.010.
Bhat, K. et al. (2020), "1-[(4-Nitrophenyl)sulfonyl]-4-phenylpiperazine treatment after brain irradiation preserves cognitive function in mice", Neuro-Oncology, Vol. 22/10, Oxford University Press, Oxford, https://doi.org/10.1093/neuonc/noaa095.
Bourgognon, J.-M. and J. Cavanagh. (2020), "The role of cytokines in modulating learning and memory and brain plasticity", Brain and Neuroscience Advances, Vol. 4, https://doi.org/10.1177/2398212820979802.
Cekanaviciute, E., S. Rosi and S. Costes. (2018), "Central Nervous System Responses to Simulated Galactic Cosmic Rays", International Journal of Molecular Sciences, Vol. 19/11, MDPI, Basel, https://doi.org/10.3390/ijms19113669.
Donzis, E. J. and N. C. Tronson. (2014), "Modulation of learning and memory by cytokines: Signaling mechanisms and long term consequences", Neurobiology of Learning and Memory, Vol. 115, Elsevier, Amsterdam, https://doi.org/10.1016/j.nlm.2014.08.008.
Fan, L. W. and Y. Pang. (2017), "Dysregulation of neurogenesis by neuroinflammation: key differences in neurodevelopmental and neurological disorders", Neural Regeneration Research, Vol. 12/3, Wolters Kluwer, https://doi.org/10.4103/1673-5374.202926.
Gonzalez, P. V. et al. (2009), "Memory impairment induced by IL-1β is reversed by α-MSH through central melanocortin-4 receptors", Brain, Behavior, and Immunity, Vol. 23/6, Elsevier, Amsterdam, https://doi.org/10.1016/j.bbi.2009.03.001.
Goshen, I. et al. (2007), "A dual role for interleukin-1 in hippocampal-dependent memory processes", Psychoneuroendocrinology, Vol. 32/8–10, Elsevier, Amsterdam, https://doi.org/10.1016/j.psyneuen.2007.09.004.
Gray, S. L. et al. (2015), "Cumulative Use of Strong Anticholinergics and Incident Dementia", JAMA Internal Medicine, Vol. 175/3, https://doi.org/10.1001/jamainternmed.2014.7663.
Hein, A. M. et al. (2010), "Sustained hippocampal IL-1β overexpression impairs contextual and spatial memory in transgenic mice", Brain, Behavior, and Immunity, Vol. 24/2, Elsevier, Amsterdam, https://doi.org/10.1016/j.bbi.2009.10.002.
Heyser, C. J. et al. (1997), "Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain", Proceedings of the National Academy of Sciences, Vol. 94/4, National Academy of Sciences, Washington, https://doi.org/10.1073/pnas.94.4.1500.
Holmes, C. et al. (2009), "Systemic inflammation and disease progression in Alzheimer disease", Neurology, Vol. 73/10, Wolters Kluwer, https://doi.org/10.1212/WNL.0b013e3181b6bb95.
Jenrow, K. A. et al. (2013), "Selective Inhibition of Microglia-Mediated Neuroinflammation Mitigates Radiation-Induced Cognitive Impairment", Radiation Research, Vol. 179/5, BioOne, https://doi.org/10.1667/RR3026.1.
Moore, A. H. et al. (2009), "Sustained expression of interleukin-1β in mouse hippocampus impairs spatial memory", Neuroscience, Vol. 164/4, Elsevier, Amsterdam, https://doi.org/10.1016/j.neuroscience.2009.08.073.
Mousa, A. and M. Bakhiet. (2013), "Role of Cytokine Signaling during Nervous System Development", International Journal of Molecular Sciences, Vol. 14/7, MDPI, Basel, https://doi.org/10.3390/ijms140713931.
Patterson, S. L. (2015), "Immune dysregulation and cognitive vulnerability in the aging brain: Interactions of microglia, IL-1β, BDNF and synaptic plasticity", Neuropharmacology, Vol. 96, Elsevier, Amsterdam, https://doi.org/10.1016/j.neuropharm.2014.12.020.
Prieto, G. A. and C. W. Cotman. (2017), "Cytokines and cytokine networks target neurons to modulate long-term potentiation", Cytokine & Growth Factor Reviews, Vol. 34, Elsevier, Amsterdam, https://doi.org/10.1016/j.cytogfr.2017.03.005.
Pugh, C. R. et al. (2001), "The immune system and memory consolidation: a role for the cytokine IL-1β", Neuroscience & Biobehavioral Reviews, Vol. 25/1, Elsevier, Amsterdam, https://doi.org/10.1016/S0149-7634(00)00048-8.
Schram, M. T. et al. (2007), "Systemic Markers of Inflammation and Cognitive Decline in Old Age", Journal of the American Geriatrics Society, Vol. 55/5, Wiley, https://doi.org/10.1111/j.1532-5415.2007.01159.x.
Sparkman, N. L. et al. (2006), "Interleukin-6 Facilitates Lipopolysaccharide-Induced Disruption in Working Memory and Expression of Other Proinflammatory Cytokines in Hippocampal Neuronal Cell Layers", Journal of Neuroscience, Vol. 26/42, Society for Neuroscience, https://doi.org/10.1523/JNEUROSCI.3376-06.2006.
Taepavarapruk, P. and C. Song. (2010), "Reductions of acetylcholine release and nerve growth factor expression are correlated with memory impairment induced by interleukin-1β administrations: effects of omega-3 fatty acid EPA treatment", Journal of Neurochemistry, Vol. 112/4, Wiley https://doi.org/10.1111/j.1471-4159.2009.06524.x.
Tan, H. et al. (2014), "Critical role of inflammatory cytokines in impairing biochemical processes for learning and memory after surgery in rats", Journal of Neuroinflammation, Vol. 11/1, Springer Nature, https://doi.org/10.1186/1742-2094-11-93.
Yirmiya, R. and I. Goshen. (2011), "Immune modulation of learning, memory, neural plasticity and neurogenesis", Brain, Behavior, and Immunity, Vol. 25/2, Elsevier, Amsterdam, https://doi.org/10.1016/j.bbi.2010.10.015.